New Tool Uses Cancer’s Drug-Resistance Mutations to Target Tumors
SpotNeoMet, a new computational tool, harnesses drug-resistance mutations to create shared neo-antigens for broader immunotherapy against treatment-resistant cancers.
Immunotherapy
Read More
Why a 78-Year-Old Doc Traveled 9,000 km to Shanghai for CAR-T Therapy
A 78-year-old retired doctor journeyed 9,000 km to Shanghai on the Chinese mainland this year for CAR-T therapy, showcasing how global medical innovation is reshaping cancer care.